ghk-cu subcutaneous injection clinical trial dose Dosage: Protocols & Charts GHK-Cu Peptide Therapy: The Definitive
Description
Summary AOD 9604 and MOTS-C offer different benefits for metabolism and health
The standard protocol uses 2 to 3 mg GHK-Cu subcutaneously, five days per week, for 8 to 12 weeks
There are multiple ways that BPC-157 seems to interact with in helping promote wound healing and growth
Don't overcomplicate it
